Gene set enrichment analysis (GSEA) of differentially expressed genes (DEG) revealed downregulation of neuronal and NE pathways in both H82 and H146 cells treated with FHD-286, including decrease in ASCL1 targets in the SCLC-A line H146 (Fig. 2B). The gene discussed is ASCL1; the disease is small cell lung carcinoma.